Faculty Speakers
Dr. Joseph Yat Sun Chan, MBBS, FACC, FRCP, FHKAM, FHKCP
Division Chief and Honorary Clinical Associate Professor, Division of Cardiology, Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong
Dr. Chan M.B.B.S. (HKU, 1992), F.R.C.P. (Lond, 2012) is currently the Head of Division of Cardiology in Prince of Wales Hospital, Chinese University of Hong Kong. He received his training in electrophysiology in Stanford University in 1998. He was the President of Hong Kong Inter-hospital Network of Pacing and Electrophysiology from 2010 to 2012. His area of subspecialty is interventional electrophysiology and device therapy.
Prof. Sek Ying Chair, RN, MBA, PhD
Director and Professor, The Nethersole School of Nursing
Faculty of Medicine, The Chinese University of Hong Kong
Website: http://www.med.cuhk.edu.hk/eng/about_us/faculty_management/SchoolDirectors/Nursing.jsp
Prof. Chair is the Director and Professor of the Nethersole School of Nursing, Faculty of Medicine, The Chinese University of Hong Kong (CUHK); and has led the School to achieve top international rankings (QS) in 2016, 2017 and 2018. She is a Visiting Professor of Guangzhou Medical University and Central South University, China and a Fellow of the American Academy of Nursing. In Hong Kong, she was appointed by the local government as a member of the HMRF & HCPF Grant Review Boards, Food and Health Bureau and the Quality and Risk Subcommittee, North District Hospital Governing Committee, Hospital Authority. She is also the Vice-President of Hong Kong College of Cardiac Nursing and an honorary advisor for many professional organizations.
Professor Chair received her PhD in Nursing from the University of Colorado Health Sciences Center, Denver, USA. Her research interests focus on cardiovascular and critical care nursing. She has published over 100 peer-refereed journal papers on cardiovascular diseases and was widely invited to speak at international conferences. She was honored with many prestigious awards including Cardiac Nursing Awards 2007 (First Prize of Excellence or Innovation in Acute or Critical Care, and Third Prize of Excellence or Innovation in Cardiac Intervention or Surgery) by the British Journal of Cardiac Nursing and British Association for Nursing in Cardiac Care, Award of Excellence in Social Engagement 2013 and University Education Award 2016 by CUHK, and Gold Merit Award 2016 by Hong Kong Academy of Nursing. She is the Co-Editor of Connect: The World of Critical Care Nursing and an Editorial Board Member of Asian Nursing Research and Chinese Nursing Management.
Dr. Gary Chin Pang Chan, MBChB, FHKAM, FHKCP
Associate Consultant and Honorary Clinical Associate Professor, Division of Cardiology, Prince of Wales Hospital, The Chinese University of Hong Kong
Website: http://aims.cuhk.edu.hk/converis/portal/Person/4914482?auxfun=&lang=en_GB
Prof. Juliana Chan, MB ChB (Liverpool), MD (Liverpool), MRCP (UK), FRCP (Lond), FRCP (Edin), FRCP (Glasgow), FHKAM (Medicine)
Chair Professor, Department of Medicine and Therapeutics
Principal Investigator, Li Ka Shing Institute of Health Sciences
Faculty of Medicine, The Chinese University of Hong Kong
Website: http://www.mect.cuhk.edu.hk/people/julianachan.html
Prof. Chan is Chair Professor of Medicine and Therapeutics and Director, Hong Kong Institute of Diabetes and Obesity at the Chinese University of Hong Kong. She is also Chief Executive Officer, Asia Diabetes Foundation, a non-profit research organization and founding director, GemVCare, a biotech company specialized in diabetes genetic testing. She graduated from the Liverpool University, UK and is a clinician scientist specialized in diabetes and clinical pharmacology. In 1995, she established the Hong Kong Diabetes Registry to characterize the clinical course and genetic associations of diabetes. In 2007, she designed the innovative web-based Joint Asia Diabetes Evaluation (JADE) Programme which combines logistics and information technology to deliver personalized diabetes care. Over the years, she and her team has raised over USD 60 million to establish large cohorts, databases and biobanks to discover biogenetic markers for precision medicine in diabetes. She has published 500 articles and 20 book chapters and is a recipient of the Peter Bennet Epidemiology Award, Asian Association for Study of Diabetes Epidemiology Award and Chinese Women Association Innovative Clinical Care Award. She is currently leading a Lancet Diabetes Commission to advocate the use of systems and policies to close the gaps in diabetes care, data and outcomes.
Prof. Kathryn Song Eng Cheah, BSc (U of London), PhD (Cambridge)
Jimmy and Emily Tang Professor in Molecular Genetics
Chair of Biochemistry, Hong Kong of University
Prof. Cheah is an expert on molecular and developmental genetics. Her research focuses on understanding how genes are regulated and how genetic changes can cause disease. She and her group apply genetics and genomics techniques, stem cell biology and animal models to address the fundamental mechanisms underlying normal embryonic development, growth and human disease.
Some key contributions of her research team are published in leading journals such as Nature, Nature Genetics, PLoS Biology, American Journal of Human Genetics, Journal of Clinical Investigation. She discovered SOX2 is a master “hearing gene” with broad implications for understanding congenital deafness. Her group have provided molecular insights into how genetic disruption of SOX9, the master gene for development of cartilage, causes a skeletal malformation. They also discovered that the unfolded protein response causes chondrodysplasia which has broad implications for a spectrum of diseases caused by problems with protein assembly and secretion. They discovered a new process by which bones cells develop and that chondrocytes become osteoblasts which has important implications for the development of therapies for bone diseases such as osteoporosis. They also discovered genetic risk factors for degenerative intervertebral disc disease (IDD), which is a common cause of lower back pain and disability. She was a Croucher Foundation Senior Fellow, a past President of the International Society for Matrix Biology and currently serves on the Board of Directors of the International Society of Differentiation. She is a member of the Gordon Research Conferences Advisory Board for Hong Kong. In 2013 she was elected Fellow of The World Academy of Science (TWAS).
Prof. Shuk Han Cheng, BSc (Hons), PhD (London)
Chair Professor of Molecular Medicine, Department of Biomedical Sciences
Associate Dean (Learning & Teaching), College of Veterinary Medicine of Life Sciences (CVMLS)
City University of Hong Kong
Website: https://www.cityu.edu.hk/bms/profile/shukhancheng.htm
Prof. Cheng received her BSc (Hons) from the University of Hong Kong, majoring in Zoology. She received her PhD from the Royal Postgraduate Medical School, which is now part of the Imperial College, University of London. Her PhD work was on the cellular immune response of BCG vaccination, under the supervision of Prof. Denny Mitchison in the Department of Bacteriology, Hammersmith Hospital. She did postdoctoral training under the supervision of Prof. Tak Mak on molecular immune response of T cells, at the Ontario Cancer Institute in Toronto. Before joining CityU in 1997, she worked in the Departments of Paediatrics, and Orthopaedics and Traumatology, at The Chinese University of Hong Kong.
She has won many innovation awards at international exhibitions, including Grand Prix and Gold Medal as a co-inventor for the invention “in vivo testing without animal experimentation” at the 43rd International Exhibition of Inventions in 2015 and WIPO Medal for Inventors, “A World-leading Non-animal in Vivo Testing Method” presented by World Intellectual Property Organization at the 8th International Invention Fair in 2015. In addition, she has been awarded the Gold Medal at the 35th International Exhibition of Inventions, New Techniques and Products of Geneva in 2007, 2 gold awards from the Korean International Women’s invention Expositions in 2009 and 2010, Gold Award and also a Special Prize from the Patent Office of the Republic of Poland, for the invention of “Rapid-identification Kit for Meat Ingredients in Processed Food” and a Bronze Award for the invention “Transgenic fish for high-throughput biomonitoring of Toxicants” in 2011. She is the recipient of the 2015 CityU Outstanding Research Award.
She has published over 140 peer-reviewed research articles and some of them are among the Top 25 Hottest Articles in the Science Direct database. Her H-factor is 32. To date she has supervised 23 graduate students, with 9 awarded PhD and another 9 awarded MPhil. She has also supervised 16 postdoctoral fellows. She is a member of the Advisory Committee on Admission of Quality Migrants and Professional; Enterprise Support Scheme (ESS) Assessment Panel of Innovation and Technology Commission, Research Project Vetting Subcommittee; Editorial Board of the journal Nanomedicine: Nanotechnology, Biology and Medicine. She is an overseas Fellow of the Royal Society of Medicine (London). She also serves on the Board of Directors of Nano and Advanced Materials Institute Limited (NAMI) in Hong Kong, and acts as the vice-chair of the Technical Committee in NAMI.
She takes great interest in teaching and mentoring undergrad students. She teaches the BSc course “Technology for Regenerative Medicine” and also coaches non-Biology major students on using biotechnology in business plans for entrepreneur competitions. She is on the Scientific Advisory Board of the Biotechnology company Vitargent.
She also holds the concurrent appointment as Chair Professor of Molecular Medicine in the Department of Biomedical Sciences and as the Associate Dean (Learning & Teaching) in the College of Veterinary Medicine and Life Sciences (CVMLS).
Prof. Bernard Man Yung Cheung, MA, MB BChir (Cantab), PhD (Cantab), MRCP (UK), FRCP (Edin), FRCP (Lond), FCP, FHKCP, FHKAM (Medicine)
Sun Chieh Yeh Heart Foundation Professorship in Cardiovascular Therapeutics
Website: http://www.medic.hku.hk/staff_detail.php?id=11
Prof. Cheung was educated at Sevenoaks School and the University of Cambridge, England. He was a British Heart Foundation Junior Research Fellow at Cambridge before taking up lectureships at the University of Sheffield and the University of Hong Kong. In 2007-2009, he held the chair in Clinical Pharmacology and Therapeutics at the University of Birmingham, England. Bernard Cheung is the Sun Chieh Yeh Heart Foundation Professor in Cardiovascular Therapeutics and heads the Division of Clinical Pharmacology and Therapeutics in the Department of Medicine of the University of Hong Kong. He is also the Director of the Institute of Cardiovascular Science and Medicine, as well as the Medical Director of the Phase 1 Clinical Trials Centre.
Prof Cheung's main research interest is in cardiovascular diseases and risk factors, such as hypertension and the metabolic syndrome. He is a principal investigator of the Hong Kong Cardiovascular Risk Factor Prevalence Study. He has published over 200 papers and 11 book chapters, and is the Chief Editor of Open Diabetes and the World Journal of Hypertension. He is a member or fellow of many distinguished societies. He is a Governor of the International Society of Cardiovascular Pharmacotherapy and the President of the Hong Kong Pharmacology Society.
Dr. Gary Shing-Him Cheung, MBBS (HK), MRCP (UK), FHKCP, FHKAM (Medicine)
Associate Consultant and Honorary Clinical Assistant Professor, Division of Cardiology, Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong
Honorary Secretary, Hong Kong Society of Congenital & Structural Heart Disease
Dr. Cheung graduated from the University of Hong Kong in 2002, and completed his general medical and cardiology training at Pamela Youde Nethersole Eastern Hospital. He received Hong Kong Heart Foundation scholarship in 2012 to further undergo one year overseas training in the field of congenital and structural heart intervention in the Copenhagen University Hospital of Denmark.
Dr Cheung is currently the Associate Consultant and the Head of Structural Heart Intervention in the Department of Medicine & Therapeutics at the Prince of Wales Hospital, Hong Kong; and Honorary Clinical Assistant Professor of the Department of Medicine & Therapeutics, Chinese University of Hong Kong. He is also the Honorary Secretary of Hong Kong Society of Congenital & Structural Heart Disease (HKCASH). His special interests are transcatheter aortic valve implantation (TAVI), percutaneous mitral valve repair (MitraClip) and left atrial appendage occlusion (LAAO). He is currently a physician proctor of Watchman and Amulet LAAO devices.
Prof. Yiu-fai Cheung, MBBS(HK), MD(HK), MRCP(UK), MRCPCH(UK), FHKCPaed, FHKAM(Paediatrics), FRCPCH(UK), FRCP(Edin)
Clinical Professor and Bryan Lin Professor in Paediatric Cardiology
Department of Paediatrics and Adolescent Medicine, LKS Faculty of Medicine, The University of Hong Kong
Prof. Cheung is the Bryan Lin Professor in Paediatric Cardiology in the Department of Paediatrics and Adolescent Medicine, LKS Faculty of Medicine, The University of Hong Kong (HKU). Professor Cheung is a clinician specialising in paediatric cardiology, a teacher, and a clinician investigator who provides specialist care for children with congenital and acquired heart diseases.
Paediatric cardiovascular science is the main focus of the professor’s research – the scope of which encompasses congenital heart disease, acquired heart disease, and vascular function in health and disease. His research interests include exploration of novel echocardiographic imaging technologies in the early detection of cardiac dysfunction in children and adolescents with complex congenital heart disease and acquired cardiomyopathies, the translation of these new imaging technologies for paediatric clinical application, and defining the structural and functional alteration of blood vessels in children at risk of premature vascular aging. He and his team work in a laboratory specifically dedicated for research in paediatric echocardiography and vascular physiology, and which is equipped with novel non-invasive modalities for comprehensive assessment of cardiovascular function in children.
Prof. Cheung provides specialist clinical service for children and adults with congenital heart disease and children with acquired heart diseases. Together with other paediatric cardiologists at Queen Mary Hospital, he provides diagnostic evaluation, postoperative care, and transcatheter interventions for patients ranging from neonates with critical heart conditions to grown-up congenital heart patients. He has been recognised internationally for his clinical expertise in paediatric cardiac imaging and catheter interventions and frequently invited to give talks on these areas on the Mainland and abroad. He is also the principal investigator in Hong Kong of an international drug trial involving children with congenital heart disease and trials responsible for assessing the cardiac function of children and young adults with beta-thalassaemia major and cancers.
Prof. Cheung graduated from HKU in 1990. He received his Doctorate of Medicine in 2004, became a full professor at the University in 2007, and was awarded the Faculty Teaching Medal in the same year. He is Chairman of the Board of Studies of Master of Medical Sciences programme and is a member of the Education Committee and helps to co-ordinate undergraduate teachings of medical students. Externally, he is a member of the Examination Committee of Hong Kong College of Paediatricians. He serves as examiner of the MBBS examinations, MRCPCH clinical examination, and Licensing Examination of the Medical Council of Hong Kong. He is responsible for the teaching of paediatric cardiology to medical students, paediatric residents, and cardiology fellows.
He has written more than 130 peer-reviewed papers, two books, and nine book chapters, produced a multimedia CD-ROM on diagnosis of congenital heart disease, and delivered more than 100 invited lectures. In addition, he is the co-director of a Child Health Survey of approximately 7,500 Chinese children of local residents aged 15 years and below being commissioned by the Department of Health.
Dr. Wai Kin Chi, MBChB, MRCP
Division of Cardiology, Department of Medicine and Therapeutics, Prince of Wales Hospital, Hospital Authority
Dr. Chi graduated from The Chinese University of Hong Kong is currently under the Division of Cardiology for post-graduate training. His main clinical and research interest is endovascular treatment including percutaneous coronary and peripheral vascular interventions.
Dr. Elaine YK Chow, BSc (London), MBChB (Hons), MSc Clinical Research (Sheffield), PhD (Sheffield), MRCP (UK)
Clinical Lecturer, Phase 1 Clinical Trial Centre and Department of Medicine & Therapeutics
Faculty of Medicine, The Chinese University of Hong Kong
Honorary Resident, Prince of Wales Hospital
Website: http://www.mect.cuhk.edu.hk/people/elainechow.html
Dr. Chow received her training in Diabetes and Endocrinology in UK before joining the Chinese University of Hong Kong in 2015. She was awarded the NIHR Biomedical Research Fellowship at the University of Sheffield in 2011. She completed her PhD on “Mechanisms of hypoglycaemia related sudden cardiac death in Type 2 diabetes”, evaluating proarrhythmic and prothrombotic effects of hypoglycaemia through continuous glucose monitoring and glucose clamp studies. She has collaborated with cardiologists at the University of Sheffield and University of Leeds, examining the effect of hypoglycaemia on platelet function and clot structure. Her work has been published in leading diabetes journals. She is currently principal investigator for a number of studies on continuous glucose monitoring and has a particular interest in use of devices and newer glucose lowering agents in prevention of hypoglycaemia.
Prof. Yi-mei Du, MD, PhD
Professor, Department of Cardiology, Research Center of Ion Channelopathy, Institute of Cardiology,
Key Laboratory for biological targeted therapy of Education Ministry and Hubei Province, Union Hospital, Tongji Medical College,
Huazhong University of Science and Technology
Jiefang Avenue 1277, Wuhan, Hubei, 430022, P.R.China
Prof. Du is a professor at the Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology. She received her Ph.D in physiology at Tongji Medical College, Huazhong University of Science and Technology and received three and a half years of postdoctoral training at the Department of Physiology, Texas Tech University Health Sciences Center in the US. She focuses solely on research at Union Hospital, Tongji Medical College. Her main research interests include but are not limited to the roles of ion channels in the pathophysiology of cardiovascular diseases. Dr. Du has published more than 70 articles in academic journals, including Circulation-Arrhythmia and Electrophysiology, Cell Death and Disease, and Journal of Molecular and Cellular Cardiology.
Prof. Wendy Keung, BSc, MPhil, PhD
Research Assistant Professor, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine
Dr. Li Dak-Sum Research Centre, HKU - Karolinska Institutet Collaboration in Regenerative Medicine, University of Hong Kong
Website: http://hub.hku.hk/cris/rp/rp01887
Prof. Keung is currently a Research Assistant Professor at the Dr. Li Dak Sum Research Centre, The University of Hong Kong – Karolinska Institutet Collaboration in Regenerative Medicine in the University of Hong Kong. She obtained her Ph.D degree in Pharmacology at the University of Hong Kong. She received her postdoctoral training at the Mazankowski Alberta Heart Institute in Canada where her major research focus was on cardiac energy metabolism during perinatal development and in disease states. During her postdoctoral training she was awarded a number of research fellowships including the Heart and Stroke Foundation of Canada/Astra Zeneca Research fellowship. Her current research interests include investigating the role of energy metabolism in the maturation of human embryonic stem cell-derived cardiomyocytes (hESC-CMs). Another major focus of her research is to investigate the role of 3D developmental cues on the maturation of hESC-CMs as well as developing functional assays for different 3D tissue constructs for drug testing and discovery.
Prof. Alice PS Kong, MBChB (CUHK), MD (CUHK), MRCP (UK), FRCP (Glasg), FRCP (Edin), ECFMG (US), FHKAM (Medicine)
Associate Professor, Department of Medicine & Therapeutics,
Faculty of Medicine, The Chinese University of Hong Kong
Honorary Associate Consultant, Prince of Wales Hospital, Hospital Authority
Website: http://www.mect.cuhk.edu.hk/people/alicekong.html
Prof. Kong is Associate Professor in the Department of Medicine and Therapeutics at the Chinese University of Hong Kong, and Honorary Associate Consultant at the Prince of Wales Hospital, Hong Kong. Dr. Kong graduated from the Chinese University of Hong Kong and completed her training in General Medicine and Endocrinology at Queen Elizabeth Hospital, Hong Kong. She had her overseas training as postdoctoral fellow at the Division of Endocrinology, Department of Medicine at University of California, San Diego, United States between 1998 and 1999. She became a Fellow of the Hong Kong Academy of Medicine in 2000, with accreditation in Advanced Internal Medicine, Endocrinology, Diabetes and Metabolism. She is also a Fellow of the Royal College of Physicians, Glasgow and Edinburgh.
Prof. Kong is the Steering Committee Member of Joint Asia Diabetes Evaluation (JADE) program. She is the Council Member of Hong Kong Association for the Study of Obesity. Other professional association memberships include Hong Kong Society of Endocrinology, Metabolism and Reproduction and American Diabetes Association. Dr. Kong’s research interests are obesity, insulin resistance and diabetes with particular focus on lifestyle factors including sleep and diet in adults and adolescents. She is an invited reviewer for many local and international journals, including Annals of Internal Medicine, Diabetes, Clinical Endocrinology, Diabetic Medicine, etc. She is an Associate Editor of Primary Care Diabetes and an editorial board member of Current Diabetes Reports and Clinical Diabetes and Endocrinology. She has presented at numerous local, regional and international meetings and has published over 190 articles in peer-reviewed journals.
Dr. Joey Kwong, PhD
Epidemiologist, JC School of Public Health & Primary Care,
Faculty of Medicine, The Chinese University of Hong Kong
Dr. Kwong is currently Epidemiologist, JC School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong and Co-Convenor of the Cochrane Adverse Effects Methods Group. She is a registered pharmacist in the UK and received her Master of Pharmacy degree and PhD in Medicinal Chemistry from the University of Bath, UK. Her previous roles include Managing Editor, Cochrane Heart Group, London School of Hygiene and Tropical Medicine, UK; Research Assistant Professor, Department of Medicine and Therapeutics, The Chinese University of Hong Kong; and Associate Professor and Executive Associate Director, Chinese Evidence-Based Medicine Centre & Chinese Cochrane Center, West China Hospital, Sichuan University, Chengdu. China.
Her main research interests are cardiovascular safety research associated with the use of drugs and medical devices, and effective translation of patient-centered safety outcome research into practice guidelines.
Prof. Xiang-qian Lao, MB (Sun Yat-sen), MM (PUMC), PhD (HKU)
Assistant Professor, JC School of Public Health and Primary Care
Faculty of Medicine, The Chinese University of Hong Kong
Website: https://www.sphpc.cuhk.edu.hk/xqlao
Dr. Lao obtained his medical degree from Sun Yat-sen Medical University and then served as a Public Health Physician for many years in the Guangzhou No. 12 Hospital (Guangzhou Occupational Disease Prevention and Treatment Hospital). He further pursued his Master of Medical Science in Peking Union Medical College and Doctor of Philosophy in the University of Hong Kong, respectively. He received post-doctoral training at Duke University Medical centre.
Dr. Lao is an epidemiologist whose main research interests lie in health effects of air pollution and cardiovascular disease. He has published his research in highly prestigious medicine journals including The Lancet Planetary Health, Environmental Health Perspectives, and International Journal of Epidemiology. Dr Lao’s research has been reported by various media organisations worldwide, such as Reuters, Newsweek and South China Morning Post. He was invited by the Hong Kong government to join the Working Group responsible for reviewing and tightening Hong Kong’s air quality standards.
Dr. Yuk-Kong Lau, MBBS (HK), FHKCP, FHKAM (MEDICINE) FRCP (LONDON), FRCP (EDINBURGH), FACC
Honorary Consultant, Department of Cardiology, Ruttonjee & Tang Shiu Kin Hospitals
Honorary Clinical Associate Professor, University of Hong Kong
President, Hong Kong College of Cardiology
Website: https://www.hkcchk.com/presidentmessage.php
After his graduation with MBBS from the University of Hong Kong, Dr. Lau pursued further medical training both in Hong Kong & in USA. He acquired three year medical residency training in Michael Reese Hospital & Medical Center/University of Chicago. Then he was selected as one of the top 5 candidates among 600 applicants to undergo three year cardiology fellowship training at Cedars-Sinai Medical Center/ UCLA at Los Angeles. He is indebted to the inspirational teaching from great clinical mentors like Prof Jeremy Swan, William Ganz, P K Shah, Gerald Maurer and Daniel Berman at CSMC. Determined to serve the local public in Hong Kong, he returned to his home town after graduation in 1993. He had then served in Grantham Hospital, Queen Mary Hospital & the Ruttonjee and Tang Shiu Kin Hospitals for over twenty years before he established his private service by December 2017.
Dr. Lau has been the major driving force in promoting professional training & education. He is the founder Chair & Program Director of the international biannual Echo Hong Kong live demonstration conference & hands-on workshops since 1997 till date. The event aims in enhancing clinical application of echocardiography for better patient care. It has become a major cardiology imaging meeting in the region which has attracted thousands of delegates all over the world. He has also taught and trained numerous clinicians & nurses from cardiology, medicine, ER, ICU and anesthesiology for the past 15 years. Dr. Lau was the Chair of the scientific committee of the Hong Kong Public Hospital Cardiologists Association for 8 years before he became the Chair of the Association from 2006-2010. He has been invited to deliver numerous lectures & talks in local, regional & international meetings, including in the Annual Scientific Meeting of the American College of Cardiology (ACC) & American Society of Echocardiography.
Dr. Lau is the President of the Hong Kong College of Cardiology, Fellow of the American College of Cardiology & the Royal College of Physicians of Edinburgh and London. He is the active trainer & examiner for higher physicians & cardiology fellows. His major interests are in management of acute coronary syndrome, transesophageal echocardiography & emergency percutaneous coronary intervention.
Dr. Lau deeply enjoys and finds greatest satisfaction in clinical patient care as well as educating the youngsters. He also likes and take time to provide voluntary community medical services and public health education. He genuinely cares and concerns about the public health care provisions for Hong Kong. He has published his views on the public health care policy and financing and has been invited to speak in the Legislative Council and various professional forums as the advocate for the public patients at large, in particularly for the sick and less privileged.
Prof. Kenneth Lee, PhD
Chief of the Developmental and Regenerative Biology Thematic Research Program, School of Biomedical Sciences
Faculty of Medicine, The Chinese University of Hong Kong
Website: http://www2.sbs.cuhk.edu.hk/en-gb/people/academic-staff/prof-lee-ka-ho-kenneth
Prof. Lee is Professor and Chief of the Developmental and Regenerative Biology Thematic Research Program at the School of Biomedical Sciences, Chinese University of Hong Kong. He obtained his BSc from the Department of Developmental Biology, University of Aberdeen, and PhD, Developmental Biology Unit, University of Glasgow, Scotland. He was also a post-doc at the University of Edinburgh studying embryo and stem cell development. Kenneth is an expert in embryology, stem cell biology and drug discovery. He has more 144 publications in international journals and a start-up companying selling stem cell-related products.
Dr. Konstantinos Letsas, MD, FEHRA, FESC
Consultant Cardiologist, Second Department of Cardiology,
Laboratory of Cardiac Electrophysiology,
Evangelismos General Hospital of Athens, Athens, Greece
Research interests: Atrial Fibrillation, Brugada Syndrome, Electrophysiology, Ablation
Dr. Letsas received his medical degree in 1997 and completed his doctoral thesis at the Medical University of Ioannina in 2003. After serving his residency in Cardiology at Evangelismos General Hospital of Athens (Greece), he completed an advanced fellowship training program of the European Heart Rhythm Association (EHRA) in Invasive Cardiac Electrophysiology at the Herzzentrum, Bad Krozingen (Germany). He received the accreditation of the EHRA in Invasive Cardiac Electrophysiology in 2008. Since 2009, he works as consultant Cardiologist/Electrophysiologist at Evangelismos General Hospital of Athens. Dr. Letsas is mainly involved in catheter ablation procedures and implantation of electrophysiological devices. His main interests include catheter ablation of atrial fibrillation, chanellopathies and sudden cardiac death in the young. He is a member of the EHRA Certification Committee. He represented Greece in the group of young Electrophysiologists of the EHRA (2013-2017). He is a Fellow of the EHRA and of the ESC. He has published more than 160 articles in peer-reviewed Journals.
Prof. Thomas WH Leung, MB ChB, MRCP, FHKCP, FHKAM
Lee Quo Wei Associate Professor of Neurology, Department of Medicine & Therapeutics
Director, Acute Stroke Unit,
Director, Kwok Tak Seng Centre for Stroke Research and Intervention,
Faculty of Medicine, The Chinese University of Hong Kong
Website: http://www.mect.cuhk.edu.hk/people/thomasleung.html
Dr. Andrew Li, MBChB, MRCP, FHKAM, FHKCP
Associate Consultant, Cardiology Division, Department of Medicine, United Christian Hospital; Honorary Clinical Assistant Professor, The Chinese University of Hong Kong
Dr. Li completed his cardiovascular imaging training in cardiac MRI, CT and Echo at the Royal Adelaide Hospital in Australia. He was accredited by the Society of Cardiovascular MR (SCMR) and American Certification Board of Cardiovascular Computed Tomography (CBCCT), and earned the SCMR Travelling Fellowship Award in 2012. He has authored peer-review publications in medical journals including American Journal of Medicine, Heart, and Clinical Radiology. He also serves as committee member of the LAAO working group in the Hospital Authority, and Echo chapter and CMR chapter of the Hong Kong College of Cardiology.
Prof. Ronald Li, PhD
Professor and Director of Ming-Wai Lau Centre for Reparative Medicine, Karolinksa Institutet (KI), Hong Kong
Professor, Dr. Li Dak-Sum Research Center, University of Hong Kong (HKU)-KI Collaboration in Regenerative Medicine, University of Hong Kong
Website: https://ki.se/en/research/ronald-li
Prof. Li is Professor and Director of Ming-Wai Lau Centre for Reparative Medicine, Karolinksa Institutet (KI), Hong Kong, with a professorial cross appointment at the Dr. Li Dak-Sum Research Center, University of Hong Kong (HKU)-KI Collaboration in Regenerative Medicine of HKU. Prof. Li is also CEO and Founder of Novoheart, a stem cell biotech company listed on the Toronto Stock Exchange under the symbol NVH with offices and laboratories in Vancouver, B.C., Irvine, California and Hong Kong. Prof Li graduated his B.S. Hons in Biochemistry/Biotechnology from University of Waterloo, Ontario, Canada on Dean's List (2nd in the graduating class), followed by completing a Ph.D. in Cardiology/Physiology at the University of Toronto. Upon the completion of his doctorate in 1998, he joined the Johns Hopkins University (JHU) School of Medicine to undertake a postdoctoral fellowship in Cardiac Electrophysiology. He was subsequently promoted to the faculty as Assistant Professor of Cardiology, and Assistant Professor of Cellular & Molecular Medicine. During his tenure at JHU, Prof Li was a 2-time recipient of the Top Young Faculty Award (2002, 2004), the Top Prize for the Young Investigator Basic Research (2001) of JHU Department of Medicine and Top Postdoctoral Fellow Helen Tausig Award (2001) of JHU School of Medicine, Young Investigator Award 1st Prize from the Heart Rhythm Society (2002), and the Career Development Award from the Cardiac Arrhythmias Research & Education Foundation (2001). In light of California's 3-billion stem cell initiative Proposition 71, Professor Li was recruited to become a tenured Associate Professor at the University of California, Davis where he founded and led the Human Embryonic Stem Cell Consortium. He later joined the Cardiovascular Research Center of Icahn School of Medicine at Mount Sinai in Manhattan as Professor and Co-Director (with Kevin Costa) of the Section of Cardiovascular Cell & Tissue Engineering. During 2010-15, Prof. Li was the Founding Director of the Stem Cell & Regenerative Medicine Consortium and S Y and H Y Cheng Endowed Professor in Stem Cell Biology and Regenerative Medicine of University of Hong Kong. In 2015, Prof. Li received the Spirit of HK Innovating for Good Award by the South China Morning Post.
With over 150 publications, Professor Li's group focuses on human heart engineering, and was the first in the world to generate genetically engineered human heart cells and also, more recently, to construct the first human stem cell-based "mini-heart" with accolades such as the Best Study of 2005 and Groundbreaking Study of 2006 by the American Heart Association, Distinguished Visiting Professorship at University of Toronto Lewar Heart Center, Distinguished Alumnus of University of Waterloo, etc. In the past decade or so, his laboratory has received over US$40 million of funding from the National Institute of Health, California Institute of Regenerative Medicine, Research Grants Council and Innovation & Technology Commission of Hong Kong, etc. Professor Li serves as a panel member or reviewer of major funding bodies such as the NIH (including the USD$70M initiative: From GWAS to iPSC: Next Generation Genetic Association Studies and the USD$76M initiative: Progenitor Cell Biology Research Hubs (U01) Award, and study sections such as Electrical Signaling, Ion Transport and Arrhythmia (ESTA), Cardiovascular Differentiation and Development (CDD), Clinician Scientist/Career Development Award (K02 and K08) Panel, etc.), AHA, Association Francaisecontre les Myopathies, United States-Israel Binational Science Foundation, Research Grants Council, Stem Cell Consortium, A*STAR/Biopolis of Singapore, Wellcome Trust and MRC of the UK, etc. One the translational and entrepreneurial end, his inventions have led to several start-ups in the United States and Hong Kong, including the latest venture Novoheart.
Prof. Tong Liu, MD, PhD
Professor of Cardiology, Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular disease,
Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University,
Tianjin 300211, People’s Republic of China
Research interests: Atrial Fibrillation
Prof. Tong is Professor of Cardiology, Deputy Director of Atrial Fibrillation Center in Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular disease, Tianjin Institute of Cardiology, Department of Cardiology, Second Hospital of Tianjin Medical University. Prof. Liu was graduated from Tianjin Medical University in 2000, and got his PhD in 2006. He received training in the research of electrophysiology in the Heart Institute, Cedars-Sinai Medical Center, Los Angeles, from 2009 to 2010. He has particular interests in cardiac electrophysiology, especially in atrial fibrillation and arrhythmias, including Inflammation and oxidative stress in the pathogenesis of atrial fibrillation, upstream therapies in the prevention and treatment of atrial fibrillation. He is the Committee Member of Chinese Society of Pacing and Electrophysiology (CSPE). He is on the editorial boards of Current Cardiology Reviews, Current Biomarkers, World Journal of Cardiology, Cardiovascular Diagnosis and Therapy, Chinese Journal of Cardiovascular Medicine. He has published more than 100 in peer reviewed medical journals including JACC, Stroke, Circulation AE, Heart, JAHA, Heart Rhythm, as first/co-first/corresponding/co-corresponding authors. His work was supported by National Natural Science Foundation of China (30900618, 81270245, 81570298).
Dr. Chole Mak, MD, PhD, FHKAM (Pathology)
Chemical Pathology & Genetic Pathology Laboratories
Department of Pathology
Princess Margaret Hospital, Hong Kong
Dr. Mak graduated from the University of Hong Kong for her medical degree in 1999. She was awarded PhD in 2008 in the Chinese University of Hong Kong and MD in 2012 in HKU respectively. Her PhD project was molecular genetics of Wilson disease and her MD project was inborn errors of metabolism and expanded newborn screening . She was admitted to the Fellowship in Chemical Pathology, the Hong Kong College of Pathologists in 2006. She obtained double scopes of practice in both
chemical pathology and genetic pathology from the Royal College of Pathologists of Australasia. She also had a MSc in Health & Hospital Management by the University of Birmingham. Chloe is active in academics with awards like RCPA Outstanding Teaching Award in 2010, Fellowship of the European Society of Human Genetics in 2009, Overseas Fellowship of the Japanese Society for Inherited Metabolic Diseases in 2007 and HA outstanding team award in 2007 and 2008. She has more than 70 publications and is reviewer of various journals. She is currently the consultant pathologist in Princess Margaret Hospital. The laboratory genetic and genomic service provides consultations, genetic counseling and more than 280 genetic tests.
Dr. Ngai-Shing Mok, MBBS(HK), FRCP (Edinburgh)
Head of Cardiac Team, Department of Medicine & Geriatrics, Princess Margaret Hospital, Hospital Authority
Past President, Hong Kong Inter-hospital Network of Pacing & Cardiac Electrophysiology (HK-IN-PACE)
Consultant, SADS (HK) Foundation
Since Dr. Mok reported the first 2 local cases of Brugada syndrome (BrS) underlying sudden cardiac death (SCD) in 1999, his main research interests were on sudden arrhythmia death syndromes (SADS) and young SCD. He pioneered the study on clinical profile and genetic basis of BrS in the local Chinese population and provided one of the earliest reports on successful use of quinidine in treating VF storm in BrS and genetic basis of fever-induced BrS. In collaboration with the Pathology Department in PMH he developed the cardiac genetic service for SADS. In 2006 he reported the first local case of catecholaminergic polymorphic VT (CPVT) in a Chinese adolescent, confirming that CPVT due to RyR2 mutation can be found in the local Chinese population. In 2013 he first reported the local use of molecular autopsy to confirm BrS in a young victim with sudden unexplained nocturnal death. In 2014 and 2016 he reported 2 local studies on SADS and young SCD. In the first study he analysed the post-mortem data over a 5-year-period and found 25% of young SCD was unexplained. In the second study, the SADS-HK Study, he performed molecular autopsy on unexplained young SCD by Next Generation Sequencing (NGS) and found pathogenic or likely pathogenic mutations in SADS-related gene in 29 % of young SCD victims. These 2 studies earned him and his team the Best Paper Awards in several local and international arrhythmia conferences.
Dr. Elena Ntatsaki, MA, MD, FHEA, FRCP
Consultant Physician, Ipswich Hospital NHS Trust
Honorary Senior Lecturer, Division of Medicine, University College Hospital and Royal Free Hospital and
University College London, UK
Dr. Ntatsaki is a consultant physician and rheumatologist at Ipswich hospital NHS Trust, UK and an honorary Senior Lecturer (Associate Professor) at University College London. She completed her training in London and the East of England (Cambridge/ Norwich) with subspecialisation in systemic lupus erythematosus, vasculitis, ultrasound for early arthritis and medical education. Her current research focuses on lupus and vasculitis. She is the lead author of the British Guidelines of the management of ANCA associated vasculitides. She currently routinely teaches junior doctors in the East of England and medical students at University College London.
Prof. Ming-Yen Ng, BMedSci(UK), BMBS(UK), FRCR(UK)
Assistant Professor, Department of Diagnostic Radiology,
Li Ka Shing Faculty of Medicine, The University of Hong Kong
Website: http://hub.hku.hk/cris/rp/rp01976
Prof. Ng is a Clinical Assistant Professor in the Department of Diagnostic Radiology, The University of Hong Kong. He is the division Chief of Cardiac Imaging at the HKU– Shenzhen Hospital, China.
Prof. Ng completed his medical degree and radiology training in the UK and sub-specialised in cardiothoracic imaging. He furthered his training by undertaking a 1 year cardiac CT and cardiac MR fellowship in Toronto General Hospital, Canada.
He has level 3 accreditation from the Society of Cardiovascular Magnetic Resonance and Society of Cardiovascular Computed Tomography.
In September 2014, Dr. Ng took up his current position in the University of Hong Kong. Whilst here, he has set up cardiac MRI services and trained staff at 3 sites in The University of Hong Kong, WanFang Hospital, Taipei and HKU-Shenzhen Hospital, China. The two sites in Hong Kong and Shenzhen have scanned >1000 patients althogether.
His current research interests are in cardiac MRI and cardiac CT.
Prof. Nazish Sayed, MS, MD, PhD
Academic Instructor, Stanford University School of Medicine
Cardiovascular Institute, Stanford University
Website: https://profiles.stanford.edu/nazish-sayed
Prof. Sayed is a junior faculty in the Stanford Cardiovascular Institute (CVI) in the Department of Medicine, Stanford University under the mentorship of Dr. Joseph C. Wu (Director of the Stanford CVI and Simon H. Sterzter Professor in the Department of Medicine. His postgraduate training at Rutgers New Jersey Medical School was in vascular biology, which focused on investigating the structure-function relation of the nitric oxide (NO) receptor, soluble guanylyl cyclase. This was followed by a productive postdoctoral fellowship in endothelial regenerative biology here at Stanford University. His NIH-funded postdoctoral work in the role of innate immunity in EC regeneration resulted in high-impact papers in Cell, and Circulation and Circ Res. As a junior faculty now at Stanford’s Cardiovascular Institute he has established an endothelial regeneration program and have become the main lead on projects related to characterization of human iPSC-derived endothelial cells (iPSC-EC). His work involves investigating the pathological mechanisms associated with cardiovascular diseases, including Dilated Cardiomyopathy using patient-specific iPSCs as a disease model. His work on EC regeneration has awarded him with the ATVB Early Career Investigator Award by the American Heart Association and the Jay D. Coffman Young Investigator Award by the Society of Vascular Medicine.
Prof. Xiaoyu Tian, BSc, MPhil, PhD
Assistant Professor, School of Biomedical Sciences,
Faculty of Medicine, Chinese University of Hong Kong
Website: http://www2.sbs.cuhk.edu.hk/en-gb/people/academic-staff/prof-tian-xiaoyu
Prof. Xiao Yu Tian is an Assistant Professor of the School of Biomedical Sciences, Chinese University of Hong Kong (CUHK). She received PhD from CUHK Department of Physiology. She studied the therapeutic effect of PPARs on vascular dysfunction in hypertension and type 2 diabetes, and mitochondrial oxidative stress in endothelial cell function. After graduation, she continued as a postdoctoral fellow in the lab of Prof. Ajay Chawla, Cardiovascular Research Institute, UCSF, studying macrophage dynamics in obesity-induced adipose tissue inflammation, and also in the atherosclerosis. She later jointed CUHK again in 2015, and is now Assistant Professor. Her current research interests include the regulation of macrophage function by molecular clock components in the vascular microenvironment of cardiovascular diseases. She also works on immune regulation of adipose tissue inflammation, and fatty acid metabolism by PPARs in the context of obesity and insulin resistance.
Prof. Gary Tse, BA (Hons.) (Cantab.), MBBS (Imperial), MA (Cantab.), MPH (Manc.), PhD (Cantab.), MFPH (UK), FESC, FACC, FSCAI, FHRS, FRCP (Glasg, Edin, Lond), FRCPCH, FFPH
Principal Investigator,
Laboratory of Cardiovascular Physiology,
Li Ka Shing Institute of Health Sciences
Hong Kong S.A.R., P.R. China
Research interests: Atrial Fibrillation, Ventricular Tachycardia/Fibrillation, Sudden Cardiac Death, Electrophysiology
Website: https://sites.google.com/view/garytse86/
Prof. Tse is a clinician-scientist with training in physiology, medicine, cardiac electrophysiology, public health and healthcare management. His research interests include the electrophysiological mechanisms of rhythm disorders. He leads a highly prolific group, authoring 144 publications (76 as first/co-first/corresponding/co-corresponding author; 113 full publications) in leading journals (impact factor in brackets) such as European Heart Journal (20), Journal of the American College of Cardiology (20), Emerging Infectious Diseases (8.1), Obesity Reviews (8.0), Journal of the American Medical Directors Association (6.6), Circulation: Arrhythmia and Electrophysiology (6.5), International Journal of Cardiology (6.2), Stroke (5.7), Heart (5.6), Journal of the American Heart Association (5.1), Heart Rhythm (4.3), Acta Physiologica (Oxford) (4.1), Europace (4.0), Frontiers in Physiology (4.0), PLoS ONE (3.1) and Journal of Arrhythmia over the past two years.
In recognition of his contributions to cardiovascular medicine, Prof. Tse has been elected to the Fellowships of the Institute of Biomedical Science, Royal Society of Public Health, European Society of Cardiology, American College of Cardiology, Heart Rhythm Society and Royal College of Physicians and Surgeons of Glasgow qua Physician. He has attracted over 9.1 million HK dollars in research-related funding and has supervised over 50 undergraduate and postgraduate students for medical research.
Prof. Shelly Lap Ah Tse, MB (Fudan), PhD (CUHK), Dip. Occ. Hyg. (CUHK), ICOH, FHKIOEH
Head, Division of Occupational & Environmental Health;
Director, Centre for Occupational and Environmental Health Studies;
Associate Professor, JC School of Public Health and Primary Care
Faculty of Medicine, The Chinese University of Hong Kong
Honorary Consultant, FM/GOPC KCC, Hospital Authority
Website: https://www.sphpc.cuhk.edu.hk/shellytse
Prof. Tse is the Director of Centre for Occupational and Environmental Health Studies. She is also the Head and Associate Professor of the Division of Occupational and Environmental Health of Jockey Club School of Public Health and Primary Care, the Chinese University of Hong Kong. She received her Bachelor of Medicine from FuDan University and obtained her PhD degree from CUHK in 2003. She received further training in NCI/NIH of USA. Now, she is serving as the Chairman of Advisory Committee/Environmental Hygiene (CUHK), Honorary Advisor (FM/GOPC KCC)/Hospital Authority, member of Drinking Water Safety Advisory Committee and Prevention of Legionnaires’ Disease Committee of Hong Kong SAR Government, editor of Hong Kong Medical Journal, and visiting professor of Nanjing Medical University/China. She is leading several research projects funded by the Research Grant Council, NCI/NIH of USA, Health Medical Research Fund and National Natural Science Foundation of China (NSFC) regarding health impacts of nightshift work and bisphenol A (BPA) on breast cancer, prostate cancer, and metabolic syndromes. She is the CUHK PI leader of tripartite collaboration with Utrecht University and University of Toronto on exposome and public health. She has close collaborations with the SYNERGY Project led by IARC/WHO regarding occupational exposures and lung cancer. Shelly received Second Class Award of State Scientific and Technological Progress Award in 2014/2015 on silicosis, mechanisms and prevention, and until now she has about 150 research publications.
Prof. Cheuk-Kit Wong, MBBS, MD, FHKAM, FHKCP
Division of Cardiology, Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong
Website: https://scholars.croucher.org.hk/scholars/wong-cheuk-kit
Prof. Wong is an Adjunct Professor in the Department of Medicine and therapeutics, Chinese University of Hong Kong. He has led a series of work from the international HERO-1 and HERO-2 trials evaluating the electrocardiographic features in patients with acute ST elevation myocardial infarction. He believes that for the heart surface electrical signals reflect physiological and pathological processes, and the ECG features best “phenotype” the evolving STEMI process. Modern technologies such as smart phones with dedicated apps, etc allow ECG signals to be captured, transmitted, centralized, and analysed. Future management may be refined by better sub-classification of STEMI.
Dr. Edmond Man-lok Wong, MBBS FHKCP FHKAM FRCP FRACP FACC
Consultant Cardiologist, Hong Kong Baptist Hospital and Honorary Clinical Associate Professor, Department of Medicine and Therapeutics, The Chinese University of Hong Kong
Dr. Wong graduated from the University of Sydney with first class honors in 1996 and received his cardiology training at the Royal Prince Alfred Hospital in Sydney, Australia. He returned to Hong Kong in 2005 and started his cardiology practice at the Prince of Wales Hospital. He is currently consultant cardiologist at the Hong Kong Baptist Hospital and honorary clinical associate professor of the Chinese University of Hong Kong. He subspecializes in interventional cardiology and has delivered lectures locally and internationally on clinical cardiology and complex coronary artery interventions.
Prof. Ian Chi Kei Wong, B.Pharm (Hons), MSc, PhD
Chair Professor and Director, Centre for Safe Medication Practice and Research, University College London, and
Lo Shiu Kwan Kan Po Ling Professorship in Pharmacy, University of Hong Kong
Website: http://www.ucl.ac.uk/pharmacy/people/academic-research-staff-profiles/ian-wong
Prof. Wong Chi-Kei is Co-Director of the Centre for Safe Medication Practice and Research of University of Hong Kong (HKU) and recipient of the Lo Shiu Kwan Kan Po Ling Professorship in Pharmacy at HKU. He is also a Chair Professor at the UCL School of Pharmacy, London.
Prof. Wong has obtained over £5 million in research grants as the principal applicant, and approximately £150 million as co-applicant to conduct clinical pharmacology research. His research is focused on application of big data for pharmacoepidemiology and medicines for children’s research. Professor Wong was also an advisor to the Department of Health in England and Hong Kong, the World Health Organisation, European Medicines Agency, and the pharmaceutical industry. He has 220 peer-reviewed papers published in prominent journals, including JAMA, JAMA Internal Medicine, JAMA Psychiatry and British Medical Journal. Currently, he serves as an Executive Editor of the British Journal of Clinical Pharmacology. Prof. Wong was listed in the Top 1% Scholars (pharmacy and pharmacology) in 2015, 2016 and 2017, according to Clarivate Analytics’ Essential Science Indicators.
In association with the UCL School of Pharmacy and Great Ormond Street Children’s Hospital, Prof. Wong set up Therakind in 2006. Therakind developed Buccolam® for treatment of acute seizures in children and Ayendi Nasal Spray® for treatment of acute severe pain in children; both were granted licenses by the European Medicines Agency, and the Medicines and Healthcare product Regulatory Agency. Buccolam® was granted the first “Paediatric Use Marketing Authorisation” under the new European regulation to encourage research and development of medicines for children. He is also the Founding Director of the UCL Centre for Paediatric Pharmacy Research, which is recognised as a leading research centre in medicines for children.
In recognition of his contribution to research in drug safety and medicines for children, Prof. Wong was awarded the Chemist and Druggist Pharmacy Practice Research Conference Medal by the Royal Pharmaceutical Society of Great Britain in 2004, an Honorary Fellowship by the Royal College of Paediatrics and Child Health in 2011, an Honorary Fellowship by the College of Pharmacy Practice in Hong Kong in 2013, and a Fellowship by the Royal Pharmaceutical Society of Great Britain in 2013. He was also a recipient of the National Public Health Career Scientist Award from the Department of Health in 2002, the only pharmacist to date to have received such an award in the UK.
In 2016, Prof. Wong became Vice-President of the International Society of Pharmacovigilance (2016-2019). He has also acted as expert clinical pharmacology witness for many legal cases in the UK and Hong Kong regarding medication safety on behalf of victims of medication errors and adverse drug reactions, and pharmaceutical companies.
Prof. Jack Wong, PhD
Assistant Professor, School of Life Sciences
The Chinese University of Hong Kong
Research Interests: Vascular and metabolic biology, Stem cell biology, Cardiovascular regeneration
Website: http://www.bch.cuhk.edu.hk/jackwonglab
Prof. Wing Tak Jack Wong earned his Ph.D. in Physiology from the Chinese University of Hong Kong in 2009. To expand his horizon on cutting-edge research and technologies on stem cell biology and cardiovascular regeneration, Prof. Wong has been awarded a Postdoctoral Fellowship from American Heart Association to gain postdoctoral training at Stanford University before becoming an Assistant Professor of Houston Methodist Research Institute and Weill Cornell Medicine of Cornell University in 2013. Prof. Wong has built an active and successful research laboratory in the United States and he has been awarded an American Heart Association Scientist Development Grant, and a National Institute of Health Jump Start Award (NHLBI PCBC Jump Start Award) for his innovative research. Prof. Wong has recently relocated back to Hong Kong and become an Assistant Professor in School of Life Sciences of the Chinese University of Hong Kong. Prof. Wong has published over 60 research papers and review articles in the area of vascular medicine and biology in high impact journals including Circulation, Circulation Research, Cell Metabolism, Hypertension, Diabetes, Antioxidants & Redox Signaling, Arteriosclerosis, Thrombosis and Vascular Biology, Cardiovascular Research, Journal of Hypertension, and Radiology (Citation over 2000 with a h-index of 28). Prof. Wong has attended a number of international and regional conferences, and received numerous awards and prizes at these meetings. Prof. Wong was awarded the Young Investigator Award in American Heart Association Scientific Sessions in 2011 and 2012. He was frequently invited to review manuscripts for many international scientific journals. Furthermore, Prof. Wong is currently an Academic Editor for Archives of Current Research International and an editorial board member for Food and Nutritional Sciences, Dataset Papers in Medicine, Vascular Medicine, and World Journal of Pharmacology. Prof. Wong has also served as a peer review committee member for the AHA study sections and as an external reviewer for University of Macao and for the National Natural Science Foundation of China.
Prof. Martin C.S. Wong, BMedSc (Hons), MSc (Hons), MBChB, MD (CUHK), MPH, MBA, FRACGP, FRSPH, FHKCFP, FHKAM (Fam Med), DCH (Ire), FESC, FACC, FAcadTM, FFPH, FHKAN (Hons)
Professor and Associate Director (General Affairs), JC School of Public Health and Primary Care
Professor, Institute of Digestive Disease
Professor, State Key Laboratory of Digestive Disease
Professor (by courtesy), Department of Sports Science and Physical Education
Director, CUHK JC Bowel Cancer Education Centre, Faculty of Medicine, The Chinese University of Hong Kong
Website: https://www.sphpc.cuhk.edu.hk/martinwong
Prof. Martin C. S. Wong is a specialist in Family Medicine and an expert in the field of colorectal cancer screening and cardiovascular pharmacology. Prof. Wong has composed over two hundred publications in international peer-reviewed journals, and received over ten international and local research awards for his studies in his area of expertise. His work has been published in the Lancet, JAMA Oncology, BMJ, Gastroenterology, Gut, European Heart Journal, European Urology, and American Journal of Gastroenterology. He is a reviewer for the Medical Research Council (MRC), United Kingdom and an external reviewer of the Public Policy Research Funding Scheme, Research Grant Council (RGC). He has been selected for the “Master Teacher” and the “Annual Teacher of the Year Award” for seven years.
Prof. Wong has extensive experience in management of patients with cardiovascular diseases including complicated hypertension, diabetes, heart failure, stroke and arrhythmia via the innovative Risk Assessment and Management Programme (RAMP). In the community, he has acted as a speaker for more than 400 health seminars at both local and international levels, and is also a consultant/director in more than 30 governmental committees and NGOs serving the chronically disabled and the needy. He was appointed by the Government as the convener of the Advisory Group on Hong Kong Reference Framework for Care of Diabetes and Hypertension in Primary Care Settings. He is currently serving as a member of the Health Care and Promotion Fund (HCPF) Committee and co-chairman of the HCPF promotion subcommittee. Prof. Wong is the only person in Hong Kong who received the Global Fervent for Love of Lives Medal from the Taiwan Cultural and Educational Foundation (2011-2012), an award recognized by the international media as “Nobel Prize of Lives”. He was elected as the Ten Outstanding Young Person of Hong Kong in 2012. He was conferred as an Honorary Fellow by the Hong Kong Academy of Nursing in 2016 in recognition of his contributions to primary care. He was appointed as the Editor-in-Chief of the Hong Kong Academy of Medicine in 2017; a Fellow of the American College of Cardiology; a Fellow of the European Society of Cardiology; and a Fellow of the Faculty of Public Health in 2018.
Prof. Sunny Hei Wong, MBChB (Hons) (CUHK), DPhil (Oxon), MRCP, FHKAM, FHKCP, FRCP, FRCPath
Assistant Professor, Division of Gastroenterology and Hepatology
Department of Medicine and Therapeutics
Principal Investigator, Li Ka Shing Institute of Health Sciences
Faculty of Medicine, The Chinese University of Hong Kong
Research interests: Host-microbiome interaction in infectious and digestive diseases, Colorectal cancer screening
Website: http://www.mect.cuhk.edu.hk/people/sunnywong.html
Prof. Wong is an Assistant Professor at the Institute of Digestive Disease and Department of Medicine & Therapeutics in the Chinese University of Hong Kong. After obtaining his medical qualification, he received his doctorate training at the University of Oxford to work on human genetics and infectious diseases. His work has contributed to the identification of major genetic loci in tuberculosis, leprosy and malaria. He has won a number of awards including the Human Genome Organization Travel Award, the Croucher Foundation Award and the Hong Kong College of Physicians Young Investigator Award. He has published over 70 peer-reviewed articles including papers in Nature Genetics, Nature Communications, PLoS Pathogens and Gut. His research interest is to understand the host-microbe relationship in digestive diseases including colorectal cancer and inflammatory bowel diseases, and to explore novel biomarkers and therapeutic agents.
Prof. Yunlong Xia, MD PhD
Professor, Department of Cardiovascular Medicine,
President, Cardiovascular Hospital of Dalian Medical University
Vice President, First Affiliated Hospital of Dalian Medical University
Dalian, P.R. China
Prof. Xia currently acts as the vice-chairman of the Youth Committee of Chinese Society for Cardiac Pacing and Electrophysiology, member of Committee of Non-invasive Electrocardiology and Fundamental Research Group, Youth Committee of Chinese Society for Cadiovasucular Disease, Advisory Board for the National Medical Examination Center, and the supervisor of the training of National Qualification for Interventional Diagnosis and Treatment of Arrhythmia, the member of Youth Committee of Chinese Heart Rhythm Society, Committee of Society for Cardiovascular Disease of Cross-Straits Medicine Exchange Association, member of Committee and academic secretary of Liaoning Society for Cardiac Pacing and Electrophysiology. He is also a board member of International Society for Holter and Noninvasive Electrocardiology.
Prof. Xia has been the director and principal investigator in several national projects and received national and international awards for his outstanding achievement. He is also authors and co-authors for dozens of article and book chapters.
Prof. Vassilios Vassiliou, MBBS, MA, PhD, MRCP, FHEA, FESC, FACC
Clinical Senior Lecturer (Associate Professor), Division of Cardiology,
Norwich Medical School, United Kingdom
Website: https://www.uea.ac.uk/medicine/people/profile/v-vassiliou
Research interests: Cardiac Magnetic Resonance Imaging, Cardiomyothies
Prof. Vassiliou is a Senior Clinical Lecturer in Cardiovascular Medicine at the University of East Anglia and an honorary consultant cardiologist at the Norfolk and Norwich University Hospital, Norwich, Royal Papworth Hospital, Cambridge and the Royal Brompton Hospital, London, UK. He studied medicine at UCL, London and did my postgraduate training initially in internal medicine and then in cardiology in Cambridge and London where he received level 3 accreditation from both the Society of Cardiovascular Magnetic Resonance and the European Society of Cardiovascular Magnetic Resonance. He hold a Master’s Degree in Medical Education from the University of Bedford and a PhD in Cardiovascular Magnetic Resonance tissue characterisation from Imperial College London. My research interests are both clinical and basic science focusing on valvular heart disease, arrhythmia, heart failure and crdiac imaging. He also have an interest in epidemiological research and he is a nucleus committee member for the Population, Epidemiology and Prevention Section of the European Society of Preventive Cardiology.
Prof. Jean Woo, BA (Hons.) (Cantab), MB BChir (Cantab), MA (Cantab), MRCP, MD (Cantab), FRCP (Lond, Edin), FRACP, FFPH
Emeritus Professor of Medicine, Henry G Leong Research Professor in Gerontology and Geriatrics, and Director of the Hong Kong Jockey Club Institute of Aging, The Chinese University of Hong Kong.
Website: http://www.mect.cuhk.edu.hk/people/jeanwoo.html
Prof. Woo is Emeritus Professor of Medicine, Henry G Leong Research Professor in Gerontology and Geriatrics, and Director of the Hong Kong Jockey Club Institute of Aging, The Chinese University of Hong Kong. Her research interests include chronic diseases affecting elderly people, health services research, nutrition epidemiology, and quality of life issues at the end of life.
Dr. Jacqueline Yuen, AB (Harvard), MD (University of Michigan), DABIM, DABIM (Geriatrics)
Clinical Lecturer, Department of Medicine & Therapeutics
Faculty of Medicine, The Chinese University of Hong Kong
Website: http://www.mect.cuhk.edu.hk/people/jacquelineyuen.html
Dr. Yuen is Clinical Lecturer in the Faculty of Medicine, The Chinese University of Hong Kong (CUHK). She is a specialist in geriatrics and palliative medicine. Her research is focused on improving communication with patients with serious illness and their families and end-of-life care decision-making. She has led numerous trainings on serious illness communication for health care professionals from multiple disciplines in the United States and Hong Kong. She is a faculty trainer for VitalTalk, a nonprofit organization that provides advanced communication training courses and train-the-trainer programs for faculty in the United States and globally. She is currently leading trainings to build capacity of healthcare providers in Hong Kong to provide quality end-of-life care and is developing a new service model to meet the needs of patients with advanced heart failure.
Prof. Xiaoqiang Yao, BBS, MS, PhD
Professor, School of Biomedical Sciences, Chinese University of Hong Kong, Hong Kong
Website: https://www.lihs.cuhk.edu.hk/en-us/research/investigators/yaoxiaoqiang.aspx
Prof. Yao obtained his degree of Bachelor of Science in Biology in 1981 from Department of Biology, Hangzhou University, Zhejiang, China. In 1984, he obtained his Master of Philosophy degree from Shanghai Institute of Plant Physiology, Chinese Academy of Sciences. He then obtained his Ph.D. degree in 1991 from Department of Biological Sciences, The State University of New York at Buffalo, Buffalo, USA. After that, he had two periods of postdoctoral training, one in University of California at Riverside and another in Department of Internal Medicine, Yale University School of Medicine, USA. In 1996, he became an Assistant Professor in Department of Physiology, Chinese University of Hong Kong, and later was promoted to Associate Professor in 1999 and Professor in 2002. He is now the Chief of Neuro, Vascular and Metabolic Biology Theme in the School of Biomedical Sciences, Chinese University of Hong Kong.
His research interest is mostly on ion channels in cardiovascular system and cancer cells. These include TRP channels and K+ channels. He has published more than 200 original articles with total citation of >8100 with H-factor of 50, including those in Proc Natl Acad Sci USA, Nature Communications, Circulation Research, Journal of Clinical Investigation and Trends in Pharmacological Sciences.